Clinical Trial Update: Inflammation: Correlates and Prognosis in Framingham

View source ↗

Summary

An NHLBI-sponsored Framingham study update examining the relationship between inflammation and prognosis in cardiovascular disease. The trial status is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Disease
• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED